Home » Newsletters » BioWorld Science

BioWorld Science

May 10, 2000

View Archived Issues

Karo Bio updates product development programs

Matrix achieves several important milestones in IntraDose program during Q1

SciClone updates Zadaxin progress during Q1, as well as other programs

Proteomics R&D at Incyte continues to yield new discoveries with diagnostic, therapeutic potential

Another neuropharmaceutical patent filing announced by IGT

ImmunoGen and British Biotech enter small cell lung cancer collaboration

AEterna initiates patient recruitment for phase III trial of Neovastat

Phase III study of Protegrin IB-367 Rinse begins

HIV-1-derived cationic peptide kills pathogens associated with cystic fibrosis

FDA grants fast track status to Biomira's breast cancer vaccine

FDA advisory panel recommends approval of Apligraf for diabetic foot ulcers

Novel drug safely and effectively treats acromegaly in clinical trial

New compounds from AstraZeneca for cytokine-mediated conditions

Halitulin: a new cytotoxic alkaloid isolated from sponge at Pharma Mar

Merck describes factor Xa inhibitors and their use in thromboembolic conditions

Newly issued patent covers novel antifungal series from Aventis

Naturally occurring antimicrobial flavanones discovered at RDF

Pyridyl derivatives in development at AstraZeneca for asthma, rhinitis, etc.

Potential new radiopharmaceuticals for imaging cartilage under study by French researchers

Epix grants Schering license to patents covering Eovist

Celtrix and Insmed move toward merger

Inhibition of allergen-induced increases in exhaled NO and airways hyperresponsiveness with SD-3651

American Thoracic Society meeting selected for presentation of new VLA-4 antagonist

CP1 at least as active as codeine in animal model of citric acid-induced cough

Voriconazole compares favorably to fluconazole against over 300 Candida isolates

Excellent intracellular activity and PAE of ABT-773 against Legionella spp.

Korean antiplatelet/antithrombotic agent NQ-304 reappears at recent congress

Roflumilast effective and safe in patients with exercise-induced asthma

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
FDA greenlights Medtronic Onyx subdural hematoma treatment
BioWorld MedTech
Sometimes the darkest products (names) bring a bright spot of news to their developers, as the U.S. FDA clearance for Galway, Ireland-based Medtronic plc's Onyx...